Levetiracetam protects hippocampal neurons in culture against hypoxia-induced injury

Folia Histochemica et Cytobiologica

Volumn 49, Issue 1, 2011, Pages 148-152

  Sendrowski, Krzysztof ^a   Boćkowski, Leszek ^a   Sobaniec, Wojciech ^a   Iłendo, Elzbieta ^a   Jaworowska, Barbara ^a   Śmigielska Kuzia, Joanna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hippocampal culture; Hypoxia; Levetiracetam; Neuroprotection

Indexed keywords

ETIRACETAM; LACTATE DEHYDROGENASE;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME RELEASE; HIPPOCAMPUS; IN VITRO STUDY; NERVE CELL CULTURE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; RAT;

EID: 79958180028     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0021     Document Type: Article

References (37)

1. Yakovlev AG, Faden AI. Mechanism of neural cell death: implications for development of neuroprotective strategies. Neuro Rx. 2004;1:5-16.
2. Kułak W, Sobaniec W, Wojtal K et al. Calcium modulation in epilepsy. Pol J Pharmacol. 2004;56:29-41.
3. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23: 1261-1276.
4. Artemowicz B, Sobaniec W. Rola aminokwasów pobu-dzaja{ogonek}cych w padaczce i drgawkach. Epileptologia. 1997;5: 189-207.
5. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol. 2007;20:334-342.
6. Graham SH, Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2001;21:99-109.
7. Formigli L., Papucci L., Tani A et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol. 2000;182:41-49.
8. Sendrowski K, Sobaniec-Łotowska ME, Sobaniec W. Apone-crosis of hippocampal neuronal cells in the experimental model of valproate encephalopathy. Acta Neuropathol. 2004;108:364.
9. Sendrowski K, Sobaniec W, Iłendo E, Jałosińska I. Primary culture of dissociated hippocampal neurons - the use of method in the experimental models of neuroprotection. Child Neurology. 2008;33:49-54.
10. Figiel I, Poniński P, Lukasiuk K, Kaczmarek L. Studies on effects of culture conditions and age of donor on hippocampal neurons in vitro. Folia Histochem Cytobiol. 1993;31:169-173.
11. Stepień K, Tomaszewski M, Czuczwar SJ. Profile of anticon-vulsant activity and neuroprotective effects of novel and potential antiepileptic drugs - an update. Pharmacol Rep. 2005;57:719-733.
12. Lasoń W. Endogenous anticonvulsant and neuroprotective agents. Przegl Lek. 2004;61:1263-1267.
13. Carreno M. Levetiracetam. Drugs Today (Barc). 2007;43: 769-794.
14. Abou-Khalil B. Levetiracetam in the treatment of epilepsy. Neuropsychiatr Dis Treat. 2008;4:507-523.
15. Lukyanetz EA, Shkryl VM, Kostyuk PG. Selective blockade of N-type calcium channels by levetiracetam. Epilepsia. 2002;43:9-18.
16. Lynch BA, Lambeng N, Nocka K et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004;101:9861-9866.
17. Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombi-nant protein. Eur J Pharmacol. 2006;536:102-108.
18. Custer KL, Austin NS, Sullivan JM, Bajjalieh SM. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci. 2006;26:1303-1313.
19. Brewer GJ, Torricelli JR, Evege EK, Price PJ. Optimized survival of hippocampal neurons in B27-supplemented neurobas-al, a new serum-free medium combination. J Neurosci Res. 1993;35:567-576.
20. Brewer GJ, Price PJ. Viable cultured neurons in ambient carbon dioxide and hibernation storage for a month. Neurore-port. 1996;7:150-1512.
21. Kushnareva YE, Wiley SE, Ward MW, Andreyev AY, Murphy AN. Excitotoxic injury to mitochondria isolated from cultured neurons. J Biol Chem. 2005;280:28894-28902.
22. Pitkanen A. Drug-mediated neuroprotection and antiepilep-togenesis: animal data. Neurology. 2002;59:S27-S33.
23. Trojnar MK, Malek R, Chroscinska M et al. Neuroprotective effects of antiepileptic drugs. Pol J Pharmacol. 2002;54: 557-566.
24. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1995;36:S2-S12.
25. Sendrowski K, Sobaniec W. New antiepileptic drugs - an overview. Rocz Akad Med Bialymst. 2005;50(Suppl 1):96-98.
26. Hanon E, Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure. 2001;10:287-293.
27. Wang H, Gao J, Lassiter TF et al. Levetiracetam is neuro-protective in murine models of closed head injury and sub-arachnoid hemorrhage. Neurocrit Care. 2006;5:71-78.
28. Marini H, Costa C, Passaniti M et al. Levetiracetam protects against kainic acid-induced toxicity. Life Sci. 2004;74: 1253-1264.
29. Kitano Y, Komiyama C, Makino M et al. Anticonvulsant and neuroprotective effects of the novel nootropic agent nefira-cetam on kainic acid-induced seizures in rats. Brain Res. 2005;1057:168-176.
30. Gibbs JE, Walker MC, Cock HR. Levetiracetam: antiepilep-tic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia. 2006;47:469-478.
31. Rekling JC. Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett. 2003;335:167-170.
32. Nagarkatti N, Deshpande LS, DeLorenzo RJ. Levetirace-tam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture. Neurosci Lett. 2008;436:289-293.
33. Carunchio I, Pieri M, Ciotti MT et al. Modulation of AMPA receptors in cultured cortical neurons induced by the anti-epileptic drug levetiracetam. Epilepsia. 2007;48:654-662.
34. 2+ transients and epileptiform potentials in hippocampal neurons. Neuroreport. 2003;14:471-475.
35. (2+) current in pyramidal neurones of rat hippocampal slices. Neurosci Lett. 2001;306:5-8.
36. 2+ currents. Seizure. 2001;10:279-286.
37. Cardile V, Pavone A, Gulino R et al. Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Le-vetiracetam. Brain Res. 2003;976:227-233.